Goldman Sachs’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.5M | Buy |
1,290,138
+547,464
| +74% | +$2.76M | ﹤0.01% | 2595 |
|
2025
Q1 | $4.81M | Buy |
742,674
+225,544
| +44% | +$1.46M | ﹤0.01% | 2778 |
|
2024
Q4 | $3.8M | Sell |
517,130
-315,553
| -38% | -$2.32M | ﹤0.01% | 3064 |
|
2024
Q3 | $6.24M | Buy |
832,683
+49,884
| +6% | +$374K | ﹤0.01% | 2604 |
|
2024
Q2 | $6.97M | Sell |
782,799
-119,543
| -13% | -$1.06M | ﹤0.01% | 2383 |
|
2024
Q1 | $9.14M | Buy |
902,342
+324,585
| +56% | +$3.29M | ﹤0.01% | 2114 |
|
2023
Q4 | $5.81M | Buy |
577,757
+175,543
| +44% | +$1.77M | ﹤0.01% | 2489 |
|
2023
Q3 | $3.77M | Sell |
402,214
-85,688
| -18% | -$803K | ﹤0.01% | 2678 |
|
2023
Q2 | $12M | Buy |
487,902
+92,095
| +23% | +$2.26M | ﹤0.01% | 1895 |
|
2023
Q1 | $9.21M | Sell |
395,807
-221,350
| -36% | -$5.15M | ﹤0.01% | 2076 |
|
2022
Q4 | $15.6M | Sell |
617,157
-71,625
| -10% | -$1.81M | ﹤0.01% | 1798 |
|
2022
Q3 | $13.3M | Buy |
688,782
+219,702
| +47% | +$4.24M | ﹤0.01% | 1920 |
|
2022
Q2 | $11.9M | Sell |
469,080
-148,670
| -24% | -$3.79M | ﹤0.01% | 1983 |
|
2022
Q1 | $15.9M | Buy |
617,750
+60,368
| +11% | +$1.55M | ﹤0.01% | 1884 |
|
2021
Q4 | $23.3M | Sell |
557,382
-58,713
| -10% | -$2.46M | ﹤0.01% | 1648 |
|
2021
Q3 | $26.8M | Buy |
616,095
+96,649
| +19% | +$4.21M | 0.01% | 1508 |
|
2021
Q2 | $24.6M | Sell |
519,446
-479,696
| -48% | -$22.7M | 0.01% | 1580 |
|
2021
Q1 | $51.2M | Buy |
999,142
+446,909
| +81% | +$22.9M | 0.01% | 1022 |
|
2020
Q4 | $14.8M | Buy |
552,233
+146,862
| +36% | +$3.93M | ﹤0.01% | 1783 |
|
2020
Q3 | $13.9M | Buy |
405,371
+324,934
| +404% | +$11.2M | ﹤0.01% | 1724 |
|
2020
Q2 | $3.3M | Buy |
80,437
+26,672
| +50% | +$1.09M | ﹤0.01% | 2569 |
|
2020
Q1 | $1.84M | Buy |
53,765
+40,232
| +297% | +$1.38M | ﹤0.01% | 2806 |
|
2019
Q4 | $170K | Buy |
+13,533
| New | +$170K | ﹤0.01% | 4023 |
|